LIPLASOME PHARMA ApS — Credit Rating and Financial Key Figures

LIPLASOME PHARMA ApS (CVR number: 29428514) is a company from VEJLE. The company recorded a gross profit of -28 kDKK in 2025. The operating profit was -28 kDKK, while net earnings were 62 kDKK. The profitability of the company measured by Return on Assets (ROA) was 2.7 %, which can be considered weak and Return on Equity (ROE) was 2.6 %, which can be considered weak. The equity ratio, a key indicator for solidity, stood at 99.5 %, a level that can be considered to be very good, which means that the majority of assets are financed by equity. LIPLASOME PHARMA ApS's liquidity measured by quick ratio was 199.1 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.